Author

Jonathan C. Hibbard

City Of Hope National Medical CenterORCID 0009-0001-0382-0448Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Bioengineering· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 3 Approach:experimental assay· 3 Organism:human· 3 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Assay:scRNA-seq· 2 Assay:bulk RNA-seq· 1 Assay:CITE-seq· 1

Frequent Co-Authors

Christine E. BrowniD· 3 shared Renate StarriD· 3 shared Behnam BadieiD· 2 shared Brenda AguilariD· 2 shared Heini M. NatriiD· 2 shared Nicholas E. BanovichiD· 2 shared Stephen J. FormaniD· 2 shared Zhiqiang WangiD· 2 shared

Activity by Year

2026-2026 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Christine E. BrownORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 28, 2026

Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma

Darya Alizadeh, Robyn A. Wong, Madeleine S. Maker…·Christine E. Brown

This study shows that targeting the TGFβ pathway improves CAR T cell efficacy in glioblastoma by enhancing antitumor activity and modulating the tumor microenvironment.

DOI 10.64898/2026.10.25.759450

humanmouse

𝕏 PostBluesky

Cancer BiologybioRxivPreprintSep 3, 2026

Patient-Derived Glioma Models Preserve Tumor Heterogeneity and Identify Stearoyl-CoA Desaturase1 (SCD1) as a Candidate Biomarker for Precision Immunotherapy

Margarita Gutova, Eric Ma, Heini M. Natri…·Christine E. Brown

DOI 10.64898/2026.09.01.748569

humanbulk RNA-seq

𝕏 PostBluesky

BioengineeringCancer Immunology ResearchPeer-reviewedAug 4, 2026

Meditope-Enabled Chimeric Antigen Receptors Facilitate Plug-and-Play Control of T Cells

Cheng-Fu Kuo, Zhen Tong, Yi‐Chiu Kuo…·Christine E. Brown

This study develops meditope-enabled CARs to improve T cell functionality and address tumor heterogeneity in CAR therapy.

1 citation

humanCITE-seq

𝕏 PostBluesky